https://www.clinrol.com/study/562
Efficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With...
Phase 3b study assessing efficacy and safety of remibrutinib vs. continuous ocrelizumab in patients with relapsing multiple sclerosis.
living withefficacysafetyremibrutinibswitching
https://publires.unicatt.it/en/publications/effectiveness-of-ocrelizumab-in-primary-progressive-multiple-scle/
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter,...
multiple sclerosiseffectivenessocrelizumabprimaryprogressive
https://www.nice.org.uk/guidance/TA585/evidence
Evidence | Ocrelizumab for treating primary progressive multiple sclerosis | Guidance | NICE
Evidence-based recommendations on ocrelizumab (Ocrevus) for treating primary progressive multiple sclerosis (MS) in adults
multiple sclerosisevidenceocrelizumabtreatingprimary
https://www.roche.com/media/releases/med-cor-2022-10-19
Roche to present new OCREVUS (ocrelizumab) data in multiple sclerosis and continued research into...
OCREVUS data will show significant benefit on slowing disease activity and progression in patients with treatment-naive early-stage relapsing-remitting...
to presentmultiple sclerosisrochenewocrevus
https://researchconnect.stonybrook.edu/en/projects/genentech-an-open-label-study-to-evaluate-the-effectiveness-and-s/
Genentech: An Open-Label Study to Evaluate the Effectiveness and Safety of Ocrelizumab in Patients...
in patientsgenentechopenlabelstudy
https://avesis.comu.edu.tr/yayin/d9ddce87-8463-44dd-b894-9422860e53b6/exploring-the-impact-of-wearing-off-phenomenon-in-ocrelizumab-treated-multiple-sclerosis-patients-insights-from-a-comprehensive-study
Exploring the impact of wearing-off phenomenon in ocrelizumab-treated multiple sclerosis patients:...
the impactmultiple sclerosisexploringwearingphenomenon